Overview
Performance
Portfolio
ESG
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Data as at: 03/10/2024
In
Objective
To achieve superior long-term capital appreciation from its investments by investing in life science businesses and single or multi-asset projects.
AIC sector
Management group
Company website
Launch date
26/10/2012
March
Next AGM date
05/10/2024
Domicile
Guernsey
Fund manager
Chris Hollowood
Dividend frequency
Annually
Wind-up provisions
The Company has an unlimited life.
Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
---|---|---|---|---|---|---|---|---|
719.33 | 1,146.07 | 112.60 | 179.40 | -37.24 | 0 | 0.00 | Jul | 1.93 (31/03/2024) |
Scroll
Dividends
Dividends declared in last 12 months
There have been no dividends in the last 12 months.
Performance (%)
Return type | 1 year | 3 years | 5 years | 10 years | |
---|---|---|---|---|---|
Syncona | Share price total return | -6.9 | -33.8 | -48.4 | 1.1 |
Biotechnology & Healthcare AIC sector | Share price total return | 12.7 | -9.2 | 13.6 | 108.5 |
Scroll
Share structure
Number of shares
638,835,994
33,378,638
Traded volumes (number of shares)
Yesterday | 1 month | 1 year | 5 years | |
---|---|---|---|---|
Total | 368,347 | 14,134,667 | 201,162,048 | 898,664,031 |
Average | N/A | 646,556 | 784,431 | 711,746 |
Scroll
Traded values (m)
Yesterday | 1 month | 1 year | 5 years | |
---|---|---|---|---|
Total | 0.41 | 15.91 | 240.20 | 1,652.70 |
Average | N/A | 0.73 | 0.94 | 1.31 |
Scroll
Trading details
Top holdings
Data as at : 31/03/2024
Investment | % of total assets |
---|---|
Autolus Therapeutics plc | 13.7 |
Spur Therapeutics Limited | 10.9 |
Quell Therapeutics Limited | 6.8 |
Beacon Therapeutics Holdings Limited | 6.5 |
Resolution Therapeutics Limited | 4.0 |
Purespring Therapeutics Limited | 3.7 |
OMass Therapeutics Limited | 3.5 |
Anaveon AG | 2.9 |
iOnctura B.V. | 2.1 |
Biomodal Limited | 1.5 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.